ASHEVILLE, N.C. (March 25, 2020)—Aeroflow Healthcare, a leading durable medical equipment (DME) provider and Inc. 5000 fastest growing company, announced a partnership with Oventus Medical.
Aeroflow will provide patients throughout the United States with Oventus’ obstructive sleep apnea (OSA) treatment solutions, including the O2Vent Optima, directly to consumers and via U.S. sleep clinics. Aeroflow will initially introduce Oventus products to patients in the Southeast U.S., followed by a nationwide offering.
The O2Vent Optima is an oral treatment solution for patients suffering from mild to moderate OSA. 3D printed and customized to fit each patient, the O2Vent Optima opens patients’ airways while bypassing soft tissue, maintaining stable jaw positions and resulting in steady ventilation and normal sleep.
“The U.S. is a crucial market for Oventus Medical as we look to expand our global footprint and reach as many patients as possible,” said Dr. Chris Hart, CEO of Oventus Medical. “Our strategic agreement with Aeroflow Healthcare allows us to immediately serve a large base of American patients, and is an important step in our long-term aspiration as a global medical equipment provider.”
“Aeroflow Healthcare continuously looks for solutions to patients’ problems, and working with an innovator like Oventus Medical helps us solve a major issue that many patients experience while undergoing sleep apnea treatment,” said Eric Mongeau, National Sales Director at Aeroflow Sleep. “We are eager to help Oventus bring its obstructive sleep apnea treatment solutions to patients in the U.S. southeast and across the country, as our patients seek the medical products that will provide them with the best possible treatment.”
Visit aeroflowinc.com for more information.
